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ABSTRACT
ObjeCtives
To determine the proportion of avoidable deaths (due 
to acts of omission and commission) in acute hospital 
trusts in England and to determine the association 
with the trust’s hospital-wide standardised mortality 
ratio assessed using the two commonly used methods - 
the hospital standardised mortality ratio (HSMR) and 
the summary hospital level mortality indicator (SHMI).
Design
Retrospective case record review of deaths.
setting
34 English acute hospital trusts (10 in 2009 and 24 in 
2012/13) randomly selected from across the spectrum 
of HSMR.
Main OutCOMe Measures
Avoidable death, defined as those with at least a 50% 
probability of avoidability in view of trained medical 
reviewers. Association of avoidable death proportion 
with the HSMR and the SHMI assessed using 
regression coefficients, to estimate the increase in 
avoidable death proportion for a one standard 
deviation increase in standardised mortality ratio.
PartiCiPants
100 randomly selected hospital deaths from each 
trust.
results
The proportion of avoidable deaths was 3.6% (95% 
confidence interval 3.0% to 4.3%). It was lower in 
2012/13 (3.0%, 2.4% to 3.7%) than in 2009 (5.2%, 
3.8% to 6.6%). This difference is subject to several 
factors, including reviewers’ greater awareness in 
2012/13 of orders not to resuscitate, patients being 
perceived as sicker on admission, minor differences in 
review form questions, and cultural changes that 
might have discouraged reviewers from criticising 
other clinicians. There was a small but statistically 
non-significant association between HSMR and the 
proportion of avoidable deaths (regression coefficient 
0.3, 95% confidence interval −0.2 to 0.7). The 
regression coefficient was similar for both time periods 
(0.1 and 0.3). This implies that a difference in HSMR of 
between 105 and 115 would be associated with an 
increase of only 0.3% (95% confidence interval −0.2% 
to 0.7%) in the proportion of avoidable deaths. 
A similar weak non-significant association was 
observed for SHMI (regression coefficient 0.3, 
95% confidence interval −0.3 to 1.0).
COnClusiOns
The small proportion of deaths judged to be avoidable 
means that any metric based on mortality is unlikely 
to reflect the quality of a hospital. The lack of 
association between the proportion of avoidable 
deaths and hospital-wide SMRs partly reflects 
methodological shortcomings in both metrics. 
Instead, reviews of individual deaths should focus on 
identifying ways of improving the quality of care, 
whereas the use of standardised mortality ratios 
should be restricted to assessing the quality of care 
for conditions with high case fatality for which good 
quality clinical data exist.
Introduction
For over 20 years the overall standardised mortality 
ratio (SMR) for all deaths in a hospital has been advo-
cated as an indicator of the quality (encompassing 
both safety and effectiveness) of a hospital.1  Although 
an association between the SMR for a specific disease 
(such as acute myocardial infarction, pneumonia, and 
severe sepsis) and measures of quality of care (such as 
adherence to clinical guidelines) has been shown,2-5 
similar studies on hospital-wide SMRs have not been 
reported. Despite concerns about the value of hospital- 
wide SMRs being raised by experts in the United 
Kingdom,6 United States,7 Canada,8 and Australia,9 
many countries have adopted them and continue to 
use them.
The Keogh review10  used hospital-wide SMRs to 
select acute hospital trusts (National Health Service 
organisations that comprise either a single hospital or a 
group of local hospitals) in England for detailed consid-
eration of their quality.10  This review was established in 
February 2013 in the wake of the second Francis report 
into Mid-Staffordshire NHS Foundation Trust.11 
It aimed “to review the quality of care and treatment 
provided by those NHS trusts and NHS foundation 
WhAT IS AlReAdy knoWn on ThIS TopIC
Hospital-wide standardised mortality ratios (SMRs) are commonly used as an 
indicator of a hospital’s quality but have not been validated
The proportion of hospital deaths judged to be avoidable based on retrospective 
case record review has been reported to be about 4-5%
The association between hospital-wide SMRs and the proportion of avoidable 
deaths is uncertain; one study found no association but was too small to provide 
definitive evidence
WhAT ThIS STudy AddS
The lack of a statistically significant association between hospital-wide SMRs and 
the proportion of avoidable deaths was confirmed
Both hospital-wide SMRs and avoidable death proportions based on the judgment 
of only one or two reviewers have methodological shortcomings making them 
unsuitable indicators to compare the quality of hospitals
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trusts that are persistent outliers on mortality indicators 
 [hospital-wide SMRs].” The 14 trusts selected had a 
higher than expected hospital-wide SMR for two con-
secutive years according to either of the two widely 
used metrics—the hospital standardised mortality ratio 
(HSMR) and the summary hospital level mortality indi-
cator (SHMI).
In July 2013, one of the main recommendations of the 
review was the need for a study into the relation 
between “excess mortality rates” (based on hospi-
tal-wide SMRs) and “actual avoidable deaths” (based 
on retrospective case record review by experienced 
 clinicians).12  The latter was considered to provide a 
more meaningful indication of the quality of clinical 
care, being based on clinicians’ careful and detailed 
review of each death rather than on a statistical proba-
bility derived from routine administrative data. 
Although case record review should not be considered 
as the ideal, given its known limited reliability,13 at least 
a moderately strong association between the two mea-
sures would provide some reassurance as to the validity 
of hospital-wide SMRs as a measure of mortality associ-
ated with poor quality of care.
The only published account of the relation between 
hospital-wide SMRs and proportions of avoidable 
deaths was a study of 10 acute hospital trusts in 
England in 2009.14  This found no association with the 
HSMR (correlation coefficient −0.01).15  Given the small 
sample size, however, the 95% confidence interval was 
wide (−0.64 to 0.62). Subsequently, data for SHMI were 
obtained,16 which showed that the association with that 
metric was also not significant (−0.24, 95% confidence 
interval −0.76 to 0.46).
To meet the objective of the Keogh review, we 
enlarged that study to increase confidence in the esti-
mate of the proportion of avoidable deaths determined 
by case record review and the association between the 
proportion of deaths that were avoidable (due to acts of 
omission and commission) in a trust and its HSMR 
and SHMI.
Methods
The retrospective case record review design that we 
used was an adaptation of studies conducted in the UK, 
Canada, and the Netherlands.17-20
sampling strategy
A clinically important association between hospital- 
wide SMR and avoidable death proportion would be 
indicated by a regression coefficient of at least 0.5 
(that is, an increase of 1% in avoidable death propor-
tion for an increase in HSMR of one standard devia-
tion, assumed to be 10). We report regression 
coefficients rather than correlation coefficients, for 
the reason explained below in the description of 
analyses.
We determined that, based on an avoidable death 
proportion of 5% (SD 2%),6 a sample of 34 trusts and 
100 cases per trust would have 80% power to detect 
a regression coefficient of 1.4 (that is, a 1.4 percentage 
point increase in avoidable death proportion for a 
10 point increase in SMR). Estimates of statistical power 
were based on simulated two stage sampling of 34 
trusts from a population of trusts, and then 100 cases 
per trust.
We stratified all 141 acute trusts by HSMR, and then 
used sampling to ensure that the trusts were represen-
tative for teaching status, size, and location. Using the 
hospital administration system in each of the trusts, 
staff trained in the study methods randomly selected 
the case records of 100 patients who had died in hospi-
tal during the index year. If a case record could not be 
found, a substitute patient was randomly selected. 
Information on missing case records was recorded (age, 
sex, admitting specialty, reason why missing) to check 
for sampling bias. Through assiduous searching, only 
5.3% of records were missing. We excluded obstetric, 
psychiatric, and paediatric patients (who accounted for 
<5% of all hospital deaths in England and Wales in 
2012).
Definitions
For each case, reviewers were initially asked to judge 
whether there had been any problem in care that had 
contributed to the patient’s death. We defined problems 
in care as patient harm resulting from acts of omission 
(inactions such as failure to diagnose and treat accord-
ing to evidence based guidelines), acts of commission 
(affirmative action such as incorrect treatment or man-
agement), and harm as a result of unintended or unex-
pected complications of healthcare. This definition was 
seen as more helpful than adverse event, patient safety 
incident, or error because it focuses beyond single dis-
crete incidents to take a wider view of the overall qual-
ity of care provided and its contribution to a patient’s 
death. The definition was also more likely to ensure that 
deaths related to failure to act (omissions) were rec-
ognised, particularly if these occurred over days or 
weeks.
For each case where a problem in care had been iden-
tified, reviewers were asked to make a judgment as to 
the avoidability of that death. Some problems in care 
can result from exemplary clinical practice (for exam-
ple, where there is a known risk of a complication that 
could lead to death such as a patient experiencing an 
intracerebral bleed when a thrombolytic drug had been 
appropriately administered after myocardial infarction) 
and would not be regarded as avoidable. In other cases, 
patients may have experienced a problem in care but 
their concurrent illness was so complex or severe that 
even if the problem had contributed to their death, the 
death itself was not judged avoidable during that 
admission.
Among the patients in whom an avoidable event had 
occurred, reviewers were asked to assess the likelihood 
of the death being avoidable on a Likert scale (table 1). 
For the analyses, we defined the proportion of avoid-
able deaths in a trust as those where the likelihood of 
avoidability was judged to be more than 50% (grade 4-6 
on the scale). This included deaths that were “definitely 
preventable,” “strong evidence it was preventable,” 
and “probably preventable.”
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the review process
Several activities that have been shown to improve reli-
ability were incorporated in the review process:17 18 20-22 
the use of experienced clinicians, one day reviewer 
training, provision of written guidance, ongoing sup-
port from the principal investigator (HH), the opportu-
nity to raise and discuss questions with a more 
experienced reviewer, and the use of a structured med-
ical review form.
We recruited 67 doctors, all of whom had extensive 
experience as generalists (66% currently practising, 
and 34% recently retired), and many were already 
engaged in case record reviews in their own trusts. 
When necessary, specialist medical advice was avail-
able either from other reviewers within the group or 
from elsewhere. This was most often used to obtain a 
surgical opinion when a reviewer came from a medical 
specialty.
Reviewers were allocated to trusts with which they 
had no previous connection. As reviews took place on 
site, reviewers were able to request additional materials 
such as laboratory reports stored on computer, if these 
were missing from the clinical record. All deaths con-
sidered to have an element of avoidability were dis-
cussed with an expert reviewer. This aimed to reduce 
the risk of false positive results and increase the reli-
ability of the decision.
The inter-rater reliability (the level of agreement 
between reviewers) of the judgment of avoidable deaths 
(grade 4-6) based on a random sample of 486 cases 
drawn from all trusts and subjected to double reviews 
was consistent with that of previous studies (κ 0.45, 
95% confidence interval 0.24 to 0.66).13
Medical review form
We asked the reviewers to consider all aspects of patient 
care, including nurses’ and allied health professionals’ 
notes, drug charts, and diagnostic test results. Findings 
were recorded on a structured medical review form. 
Information collected on each patient included age, 
sex, admitting specialty (medical; surgical), type of 
admission (elective; emergency), comorbidity (number 
of conditions and type), and overall impairment. In all 
cases where a problem in care was judged to have con-
tributed to death, reviewers reported the type of prob-
lem, its timing, and any associated causative or 
contributory factors before making a judgment as to 
whether the death was avoidable. Among patients in 
whom there was an element of avoidability, we also 
asked reviewers to estimate the length of life lost. 
Reviewers also rated overall quality of care on a scale 
from very poor to excellent, using a validated method,23 
with free text space to provide more detail. Although 
reviews focused on the admissions during which death 
occurred, reviewers were also asked to identify prob-
lems that occurred before that admission if these 
seemed to have contributed to a patient’s death.
The study design was similar in both data collection 
periods, although some minor improvements were 
made in 2012/13 based on our experiences in 2009. 
Within the medical review form: some additional infor-
mation on mental capacity (dementia, mental illness, 
and learning difficulties) and end of life care were 
included; questions related to comorbidities were sim-
plified; and the question on avoidability was rephrased 
to improve clarity: “Was the patient’s death due to prob-
lems in the healthcare or did problems in healthcare 
contribute to the death?” (2009); “In your judgement, is 
there some evidence that the patient’s death was avoid-
able if the problem/s in healthcare had not occurred?” 
(2012/13).
analyses
We entered anonymised data onto EpiData 3.1 and 
 analysed it using Stata (versions 12 and 13) software. Data 
on trust HSMR were obtained from Dr Foster and SHMI 
from the Health and Social Care Information Centre.
Linear regression was used to investigate the associ-
ation between trusts’ hospital-wide SMRs and avoid-
able death proportions (aggregated for the trust) rather 
than correlation because the correlation is subject to 
downward biased estimates if there is random measure-
ment error in one of the variables. In this study the 
scope for random error was far greater for avoidable 
death proportions (owing to sampling 100 deaths for 
each trust) than for hospital-wide SMRs (based on all 
deaths and admissions in a year). In contrast, down-
ward bias in the estimates of a regression coefficient 
(regression dilution bias) arises in the presence of ran-
dom error in the independent variable but will not arise 
from random error in the dependent variable which, in 
table 1 | Prevalence of avoidable deaths
grade of 
avoidability* Definition of grade
2009† 
(n=1000)
2012/13‡ 
(n=2400)
Overall 
(n=3400)
2 Slight evidence of avoidability 28 (2.8) 87 (3.6) 115 (3.4)
3 Possibly avoidable but not very likely, less 
than 50-50
33 (3.3) 68 (2.8) 101 (3.0)
4 Probably avoidable, more than 50-50 29 (2.9) 45 (1.9) 74 (2.2)
5 Strong evidence of avoidability 20 (2.0) 25 (1.0) 45 (1.3)
6 Definitely avoidable 3 (0.3) 1 (0.0) 4 (0.1)
4-6 >50% likelihood 52 (5.2) 71 (3.0) 123 (3.6)
*Reviewer assessed using Likert scale.
†“Was the patient’s death due to problems in the healthcare or did problems in healthcare contribute to the 
death?”
‡“In your judgment, is there some evidence that the patient’s death was avoidable if the problem/s in healthcare 
had not occurred?”
HSMR
Av
oi
da
bl
e 
de
at
hs
 (%
)
60 80 100 120 140
0
10
15
20
5
Fig 1 | avoidable death proportion (95% confidence interval) 
for 34 trusts by hospital standardised mortality ratio 
(HsMr)
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this analysis, was avoidable death proportion.24 The 
(aggregated) trust proportion was used as the depen-
dent variable. No weights were used because the sam-
ple size was the same for all trusts.
Binomial regression models for proportions that 
allow for extra-binomial variation were also fitted, but 
presented results are confined to the simpler linear 
regression models as the conclusions were the same. 
The count of avoidable deaths was used and the sample 
size was included as the offset.
Patient involvement
There was no patient involvement in this study.
Results
Proportion of avoidable deaths
The proportion of patients where death was judged to 
be avoidable (more than 50% likely; grade 4-6) was 123 
(3.6%, 95% confidence interval 3.0% to 4.3%, table 1). 
Fewer deaths were deemed avoidable in 2012/13 (3.0%, 
2.4% to 3.7%) than in 2009 (5.2%, 3.8% to 6.6%).
association between avoidable death proportion 
and hospital-wide sMrs
Figure 1  shows the proportion of avoidable deaths by 
HSMR for the 34 trusts. Overall, based on 34 trusts, 
there was little evidence of an association between 
HSMR and the proportion of avoidable deaths in a hos-
pital (table 2). The regression coefficient was 0.3 (95% 
confidence interval −0.2 to 0.7; P=0.23). Thus, a one 
standard deviation in HSMR such as between 105 and 
115, was associated with an increase of only 0.3% (95% 
confidence interval −0.2% to 0.7%) in the proportion of 
avoidable deaths. The regression coefficient was similar 
in both time periods (0.1 and 0.3).
A similar positive but non-significant association was 
observed for SHMI (0.3, 95% confidence interval −0.3 to 
1.0). Figure 2 shows the proportion of avoidable deaths 
for the 34 trusts.
discussion
Only weak positive associations were observed 
between the proportion of avoidable deaths in a trust 
and two commonly used standardised mortality ratio 
metrics, the hospital standardised mortality ratio 
(HSMR) or summary hospital level mortality indicator 
(SHMI), neither reaching statistical significance. A dif-
ference in standardised mortality ratios (SMRs) 
between 105 and 115 would be associated with a differ-
ence in the proportion of avoidable deaths of only 0.3 
percentage points (95% confidence interval −0.2% to 
0.7%). Even if a larger sample of trusts and cases was 
taken, it would be unlikely to reveal a clinically import-
ant association, even if it achieved statistical signifi-
cance. Thus,  hospital-wide SMRs do not provide a 
useful indication of the proportion of avoidable deaths 
in a trust.
The absence of even a moderately strong association 
is a reflection of the small proportion of deaths (3.6%) 
judged likely to be avoidable and of the relatively small 
variation in avoidable death proportions between 
trusts. This confirms what others have demonstrated 
theoretically—that is, no matter how large the study, the 
signal (avoidable deaths) to noise (all deaths) ratio 
means that detection of significant differences between 
trusts is unlikely.6
Although there was no statistically significant dif-
ference over time in the proportion of deaths in which 
reviewers judged there to be an element of avoidabil-
ity (that is, including even a slight possibility) 
between 2009 (11.3%) and 2012/13 (9.4%), there was a 
statistically significant difference in the proportion of 
deaths deemed to be more than 50% likely to have 
been avoidable (5.2% v 3.0%). An improvement in 
quality of care is only one of five factors that may have 
contributed. Firstly, in 2012/13 patients were sicker; a 
higher prevalence of several key comorbid conditions 
was reported by reviewers (for example, metastatic 
cancer 11.4% v 6.0%; chronic obstructive pulmonary 
disease 36.7% v 13.2%; heart failure 21.1% v 8.8%). 
Whether or not this was a real difference or reflected 
greater propensity to record these comorbidities, the 
impact on reviewers is likely to mean they were less 
likely to judge a death avoidable. Secondly, reviewers’ 
awareness of the use of “do not attempt resuscitation” 
orders was probably greater as a result of the wider 
use of highly visible forms in the case records plus 
changes to the medical review form, which drew their 
attention to such orders. Thirdly, there was a minor 
difference in the wording of the question about attri-
bution of avoidability. And finally, a perception is that 
there has been a change in culture in the National 
Health Service over those years,25 which might have 
table 2 | regression coefficients (95% confidence intervals) for relation* between 
avoidable death proportion and two hospital-wide standardised mortality ratio (sMr) 
metrics, the hospital standardised mortality ratio (HsMr) and the summary hospital 
level mortality indicator (sHMi)
sample of trusts 
HsMr sHMi
regression coefficient 
(95% Ci) P value
regression coefficient 
(95%Ci) P value
Overall (n=34) 0.3 (-0.2 to 0.7) 0.23 0.3 (-0.3 to 1.0) 0.29
2009 (n=10) 0.1 (-0.1 to 1.3) 0.82 -0.02 (-1.0 to 0.6) 0.56
2012/13 (n=24) 0.3 (-0.2 to 0.7) 0.26 0.5 (-0.4 to 1.3) 0.24
*Regression coefficient can be interpreted as percentage point increase in avoidable death proportion for 10 
point increase in SMR.
SHMI
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Fig 2 | avoidable death proportion (95% confidence 
interval) for 34 trusts by summary hospital level mortality 
indicator (sHMi)
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led to an increasing reluctance of reviewers to criti-
cise other clinicians.
The weak positive (although non-significant) associ-
ation between SMRs and avoidable death proportion 
seen in 2012/13, but absent in 2009, may have been that 
the reviewers were aware that the principal aim during 
this second phase of data collection was to investigate 
such an association. As such, they knew that the sam-
ple of trusts had been stratified according to HSMR and 
could easily have found out the HSMRs for the trusts 
they were studying. In 2009, reviewers were not made 
aware that the trusts were a stratified sample.
strengths and limitations of this study
This is the largest nationally representative retrospec-
tive case record review to have been conducted in 
England and one of the largest worldwide. It is the first 
published comparison of hospital-wide SMRs and esti-
mates of the frequency of avoidable deaths based on 
detailed clinician reviews of case records.
The lack of a significant association between hospital- 
wide SMRs and avoidable death proportions may 
reflect the methodological limitations of both types of 
measure. Hospital-wide SMRs, being based on routine 
administrative data, are unable to take into account 
the severity of a patient’s primary condition. In addi-
tion, they are subject to variation between trusts as 
regards clinicians’ diagnostic practice, thoroughness 
of recording comorbid conditions, use of palliative or 
end of life coding (which affects HSMR but not SHMI), 
and availability of alternative facilities for patients 
where death is imminent. Even where adjustment for 
case mix is carried out in an attempt to account for 
some of these factors, it has the potential to increase 
rather than to reduce bias in the SMR as an indicator of 
the quality of care.26
Retrospective case record review using two review-
ers has only moderate reliability, reflecting the sub-
jective element in judgments of avoidability and the 
quality of care. Despite adopting practices known to 
improve reliability (training, use of a standard review 
form, availability of expert advice), the inter-rater 
reliability was only moderate (κ 0.45), similar to that 
reported in other studies. High reliability can only be 
achieved by using five or more reviewers for each case 
record, which was not feasible.27 To minimise this lim-
itation we ensured that the 100 deaths in each trust 
were allocated to several reviewers from different spe-
cialist backgrounds rather than all being reviewed by 
one person.
Another limitation may have exaggerated the 
strength of any association. Although the reviewers 
were not informed of the trust’s HSMR or SHMI, they 
could easily have obtained such information. They may 
also have had a pre-existing view of the quality of the 
trust based on reputation and hearsay. Such knowledge 
may have influenced their judgments as to the occur-
rence of problems in care and the avoidability of deaths. 
This would have contributed to overestimating the 
association between hospital-wide SMR and avoidable 
death proportion.
Another potential limitation was restricting the 
reviewing to doctors. Although doctors were instructed 
to consider not only the medical documentation in the 
case records but also the documents from nurses and 
other professionals, the inclusion of reviewers from 
those backgrounds may have taken a different view of 
the avoidability of deaths.28
Finally, we chose to define avoidable as being at 
least a 50% likelihood of the death being avoidable, a 
definition that has wide credibility and acceptability. 
Analyses based on an even broader definition of avoid-
ability, including those with only slight evidence of 
avoidability, resulted in larger although still non-sig-
nificant regression coefficients with wider confidence 
intervals (HSMR 0.6, 95% confidence interval −0.2 to 
1.5; SHMI 0.7, 95% confidence interval −0.7 to 2.0). A 
difference in SMRs between 100 and 115 would be asso-
ciated with a difference in the proportion of such 
deaths of only 0.9%.
implications for policy
Despite the methodological limitations described, the 
low rate of avoidable deaths combined with the absence 
of a significant association between hospital-wide 
SMRs and avoidable death proportions suggests that 
neither metric is a helpful or informative indicator of 
the quality of a trust. It is potentially misleading to the 
public, clinicians, managers, and commissioners to 
praise or condemn a trust on the basis of either mea-
sure. In addition, although it was beyond the scope of 
this study, neither measure should be used as a screen-
ing test (smoke alarm) to identify poor quality trusts 
until its validity for that purpose has been rigorously 
evaluated and demonstrated.
There are, however, two ways in which consideration 
of hospital deaths may assist in assessing and improv-
ing quality. Firstly, there is evidence of the value of 
SMRs for specific groups of patients, but this requires 
not only that death is a frequent outcome (such as criti-
cal care or high risk major surgery) but also that high 
quality clinical data are available that allow adequate 
risk adjustment. Secondly, routinely reviewing case 
records of patients who die in trusts provides an oppor-
tunity for identifying local quality problems and stimu-
lating improvements. It has clinical credibility by taking 
account of the complexity of patients’ conditions and 
care, and it can indicate whether or not poor care was 
responsible for any death. Although some form of mor-
tality reviewing takes place in all acute trusts in 
England, standardisation of the process (selection of 
deaths, review forms, training of reviewers, judging 
avoidability) would help ensure adequate rigour 
throughout the hospital sector.
implications for research
Four potentially productive lines of inquiry could be 
pursued. Firstly, we will explore the relation between 
avoidable deaths and other measures of safety such as 
healthcare acquired infections, staff views of the safety 
of their hospital, and patient incident reports. Secondly, 
the validity of other possible metrics based on avoidable 
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deaths, such as weighted means of grades of avoidabil-
ity, could be explored. Thirdly, the method of determin-
ing avoidability might be improved through exploring 
other ways of defining and measuring the likelihood of 
certain events being avoidable. In addition, it would be 
interesting to explore the sensitivity of results to 
blinding reviewers to the identity of the hospital, 
although this would be expensive given the vast num-
ber of references to the identity of a hospital in a case 
record. Comparison with case records of patients who 
survive might also prove to be productive. Finally, by 
combining our data with that from other countries we 
could assess the impact of increasing the power of the 
analysis.
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